Products Eszopiclone + Placebo
Eszopiclone + Placebo Pre-clinical Completed 💤 Quiet Feb 1, 2006 → Jul 1, 2007
About Eszopiclone + Placebo Eszopiclone + Placebo is a pre-clinical stage product being developed by Sumitomo Pharma for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT00374192. Target conditions include Menopause, Insomnia.
Clinical Trials (16) NCT ID Phase Status Start Completion Indication NCT01102270 Phase 1 Completed Jan 1, 2009 May 1, 2010 Obstructive Sleep Apnea NCT00645944 Pre-clinical Completed Apr 1, 2008 Apr 1, 2011 Insomnia NCT00826111 Approved Completed Aug 1, 2007 Jul 1, 2011 Depression NCT00414037 Approved Terminated Dec 1, 2006 Dec 1, 2008 Primary Insomnia NCT00386334 Approved Completed Oct 1, 2006 Feb 1, 2008 Insomnia NCT00833547 Pre-clinical Completed Sep 1, 2006 Sep 1, 2012 Schizophrenia NCT00392041 Approved Completed Aug 1, 2006 Mar 1, 2009 Fibromyalgia NCT00365976 Approved Completed Aug 1, 2006 Sep 1, 2010 Primary Insomnia NCT00555750 Pre-clinical Completed Mar 1, 2006 Aug 1, 2008 Primary Insomnia NCT00374192 Pre-clinical Completed Feb 1, 2006 Jul 1, 2007 Menopause NCT00368056 Phase 3 Completed Apr 1, 2005 Jun 1, 2006 Primary Insomnia NCT00368160 Phase 1 Completed Mar 1, 2004 Jul 1, 2005 Insomnia NCT00367965 Phase 3 Completed Feb 1, 2004 Nov 1, 2004 Insomnia NCT00366093 Phase 3 Completed Feb 1, 2004 Jan 1, 2005 Insomnia NCT00352144 Phase 3 Completed Oct 1, 2003 Oct 1, 2004 Primary Insomnia NCT00685269 Phase 2 Completed Aug 1, 2003 Jan 1, 2004 Obstructive Sleep Apnea Syndrome
Product Company Stage Hype Score atomoxetine + placebo Eli Lilly Pre-clinical Fezolinetant + Placebo Astellas Pharma Phase 2 Cetrorelix Shionogi Pre-clinical Teriparatide (PTH 1-34) Eli Lilly Phase 2/3 Comparator: placebo + Comparator: Estrace Merck Phase 1 esmirtazapine + Placebo Merck Phase 3 Marketed low dose hormone replacement therapy Novo Nordisk Pre-clinical 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) Novo Nordisk Pre-clinical 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA) Novo Nordisk Approved estradiol, 10 mcg + estradiol, 25 mcg + placebo Novo Nordisk Phase 3 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA) Novo Nordisk Phase 1 estradiol, 25 mcg Novo Nordisk Pre-clinical estradiol, 10 mcg Novo Nordisk Phase 3 estradiol, 10 mcg + estradiol, 25 mcg Novo Nordisk Phase 1 estradiol, 10 mcg Novo Nordisk Phase 3 2 mg estradiol / 1 mg norethisterone acetate (NETA) Novo Nordisk Phase 1 estradiol, 25 mcg Novo Nordisk Phase 3 estradiol, 25 mcg Novo Nordisk Phase 3 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA) + 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA) + placebo Novo Nordisk Phase 3 estradiol, 25 mcg + estradiol, 25 mcg Novo Nordisk Phase 1
Other Products from Sumitomo Pharma